STOCK TITAN

Viking firms hold 18.8% of Adaptive Biotechnologies (NASDAQ: ADPT)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Adaptive Biotechnologies Corp: Amendment No. 4 to a Schedule 13G/A reports ownership details from Viking Global entities and removes David C. Ott as a reporting person after his retirement effective March 31, 2026.

Viking Global Investors (VGI) is reported to beneficially own 29,993,708 shares of Common Stock, equal to 18.8% of the class as of March 31, 2026. Related entities include Viking Global Performance LLC (22,002,189 shares, 13.8%), Viking Global Equities Master Ltd. (21,562,143 shares, 13.5%), Viking Long Fund Master Ltd. (7,991,519 shares, 5.0%), and Viking Global Equities II (440,046 shares, 0.3%). O. Andreas Halvorsen and Rose S. Shabet are each reported as beneficial owners of 29,993,708 shares (18.8%).

Positive

  • None.

Negative

  • None.

Insights

Viking's amendment formalizes ownership and an internal personnel change without a change in share counts.

Amendment No. 4 records the retirement of David C. Ott effective March 31, 2026 and removes him as a reporting person. The filing attributes shared voting and dispositive power across Viking entities for the same aggregate positions, consistent with Rule 13d-3 aggregation.

Because the reported stakes exceed 5% for multiple entities, future disclosures triggered by any material change in holdings or control would follow SEC reporting rules. The filing itself is declarative; it does not state any transaction, transfer of shares, or change in economic ownership.

VGI beneficial ownership 29,993,708 shares reported beneficially owned by VGI
Outstanding shares 159,697,221 shares shares outstanding as of March 31, 2026
VGI percent of class 18.8% percentage of class as of March 31, 2026
VGP beneficial ownership 22,002,189 shares reported beneficially owned by VGP
VGEM beneficial ownership 21,562,143 shares reported beneficially owned by VGEM
VLFM/VLFGP beneficial ownership 7,991,519 shares reported beneficially owned by VLFM/VLFGP
VGEII beneficial ownership 440,046 shares reported beneficially owned by VGEII
beneficially own regulatory
"VGI beneficially owns 29,993,708 shares of Common Stock"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared dispositive power regulatory
"Shared Dispositive Power 29,993,708.00"
Rule 13d-3 regulatory
"Based on Rule 13d-3 of the Securities Exchange Act of 1934"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
Schedule 13G/A regulatory
"Amendment No. 4 to a Schedule 13G/A is being filed"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.





00650F109

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G



VIKING GLOBAL INVESTORS LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Investors LP (1)(2)
Date:05/15/2026
VIKING GLOBAL PERFORMANCE LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Performance LLC (1)(2)
Date:05/15/2026
Viking Global Equities II LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Equities II LP (1)(2)
Date:05/15/2026
Viking Global Equities Master Ltd.
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Equities Master Ltd. (1)(2)
Date:05/15/2026
Viking Long Fund GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Long Fund GP LLC (1)(2)
Date:05/15/2026
Viking Long Fund Master Ltd.
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Long Fund Master Ltd. (1)(2)
Date:05/15/2026
HALVORSEN OLE ANDREAS
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of O. Andreas Halvorsen (1)
Date:05/15/2026
Shabet Rose Sharon
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Rose S. Shabet (2)
Date:05/15/2026

Comments accompanying signature: (1) Scott M. Hendler is signing on behalf of O. Andreas Halvorsen, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL PERFORMANCE LLC, on behalf of itself and VIKING GLOBAL EQUITIES II LP and VIKING GLOBAL EQUITIES MASTER LTD., and as an Executive Committee Member of VIKING LONG FUND GP LLC, on behalf of itself and VIKING LONG FUND MASTER LTD, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737). (2) Scott M. Hendler is signing on behalf of Rose S. Shabet, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL PERFORMANCE LLC, on behalf of itself and VIKING GLOBAL EQUITIES II LP and VIKING GLOBAL EQUITIES MASTER LTD., and as an Executive Committee Member of VIKING LONG FUND GP LLC, on behalf of itself and VIKING LONG FUND MASTER LTD, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Ms. Shabet on February 12, 2021 (SEC File No. 005-49737).
Exhibit Information

EXHIBIT A - JOINT FILING AGREEMENT

FAQ

Who filed the Schedule 13G/A for Adaptive Biotechnologies (ADPT)?

Viking Global entities filed the amendment. It was filed on behalf of Viking Global Investors LP, Viking Global Performance LLC, Viking Global Equities II LP, Viking Global Equities Master Ltd., Viking Long Fund GP LLC, Viking Long Fund Master Ltd., O. Andreas Halvorsen and Rose S. Shabet.

How many Adaptive Biotechnologies shares does Viking Global Investors report owning?

Viking Global Investors reports beneficial ownership of 29,993,708 shares, representing 18.8% of the class based on 159,697,221 shares outstanding as of March 31, 2026 as cited in the filing's source 10-Q.

What change does Amendment No. 4 make concerning David C. Ott?

The amendment states that David C. Ott retired effective March 31, 2026 and is removed as a reporting person because he is no longer a beneficial owner of any reported shares.

What ownership percentages are reported for other Viking entities in ADPT?

Reported percentages are: Viking Global Performance LLC 13.8%, Viking Global Equities Master Ltd. 13.5%, Viking Long Fund Master Ltd. 5.0%, Viking Global Equities II 0.3%, based on the March 31, 2026 share count in the filing.

Does the filing report any sale or transfer of Adaptive Biotechnologies shares?

No. The amendment documents beneficial ownership and the removal of a reporting person due to retirement; it does not disclose any sales, transfers, or other transactions in the reported excerpt.